Thomayer University Hospital
13
3
4
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Predictive Markers of the Course of Covid-19 Based on Biomarker Serum Amyloid A (SAA) and Genetic Markers
Role: lead
Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients
Role: collaborator
Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children
Role: collaborator
Comprehensive Intensive Stroke Rehabilitation
Role: collaborator
Faecal Microbiota Transplantation in Irritable Bowel Syndrome
Role: lead
Neuroimaging in Acute Stroke
Role: collaborator
Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis
Role: lead
COVID-19: SARS-CoV-2-CZ-PREVAL-II Study
Role: collaborator
Efficacy and Analgesic Use During the Therapy of Iatrogenic Pneumothorax Using Pleuralvent™ and Chest Tube
Role: collaborator
Czech AATD Registry
Role: lead
Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI)
Role: lead
A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension
Role: collaborator
Neonatal Procalcitonin Intervention Study
Role: collaborator
All 13 trials loaded